Base-editing technologies along with AAV engineering not only help reduce costs but can also accelerate preclinical therapeutic development.

Using an aptamer-based approach, SomaLogic can identify up to 7,000 proteins at high levels of specificity, providing real-time precision proteomics for use in the lab and the clinic. Genomics has ...

This partnership provides Aptamer access to the $1.75 billion global swine vaccine market (2024), an industry experiencing sustained demand for improved animal health solutions.

This sensor may serve as a low-cost and efficient screening tool for various neurological ... this UCF-developed device uses a specially designed aptamer—a synthetic DNA strand—to precisely ...

Pharmaceutical companies have traditionally assembled extremely expensive million-component drug libraries for high-throughput screening (HTS) directed toward possible drug targets ... affinity ...

Aptamer will receive a 10 per cent royalty on all future revenues from any vaccines incorporating the licensed Optimers, creating a scalable, global, non-dilutive revenue stream. Dr Arron Tolley ...

(Image: Wikimedia Commons, CC BY 4.0) Aptamers can be used as therapeutic agents, targeting specific disease-related molecules or pathways. For example, the FDA-approved aptamer drug Pegaptanib ...